Select Page

Atrin Pharmaceuticals Elects Jeffrey M. Dayno

Atrin Pharmaceuticals Elects Jeffrey M. Dayno, MD to Board of Directors Doylestown, PA (November 16, 2016):  Atrin Pharmaceuticals, LLC. today announced the election of Jeffrey M. Dayno, M.D., chief medical officer of Egalet Corporation, to the Atrin Board of...

Atrin Pharmaceuticals Appoints Gerhard J. Sperl

Atrin Pharmaceuticals Appoints Gerhard J. Sperl, Ph.D. as Vice President, Chemistry, Manufacturing and Controls Doylestown, PA (October 25, 2016):  Atrin Pharmaceuticals, LLC. today announced the appointment of Gerhard J. Sperl, Ph.D., as Vice President, Chemistry,...

Atrin Pharmaceuticals Awarded $300,000 Phase 1 Contract

Atrin Pharmaceuticals Awarded $300,000 Phase 1 Contract for Development of Highly Specific ATR inhibitors for Targeted Cancer Treatment Doylestown, PA (October 19, 2016):  Atrin Pharmaceuticals, Inc. today announced receipt of a Phase 1 Small Business Technology...

Ben Franklin Approves Funding

Ben Franklin approves funding for Atrin Pharmaceuticals Ben Franklin approves $2M for 10 Early Stage Companies across South Eastern PA

Poster Award Winner

Atrin Pharmaceuticals receives winning poster award at “Exploring DNA Repair Pathways as Targets for Cancer Therapy” Fusion Conference in Cancun, Mexico 12-15 Feb 2015. Prize awarded by Professor Junjie Chen and Dr. Helen Piwnica-Worms
Read More Here